Evidence map›Paper›PMID 32499216›Full record

ArticleImmunoHorizons2020

Quantitative and Qualitative Perturbations of CD8

Mikhail Pomaznoy, Rebecca Kuan, Mikaela Lindvall, Julie G Burel, Grégory Seumois, Pandurangan Vijayanand, Randy Taplitz, Robert H Gilman, Mayuko Saito, David M Lewinsohn and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical manifestations and immune response to tuberculosis.World journal of microbiology & biotechnology · 2023
    Review
  4. Role of MHC class I pathways inFrontiers in cellular and infection microbiology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. PD-1 blockade exacerbatesScience immunology · 2021
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mikhail PomaznoyDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
Rebecca KuanDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
Mikaela LindvallDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0002-0042-1353
Julie G BurelDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0003-1692-2758
Grégory SeumoisDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0002-8164-6852
Pandurangan VijayanandDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
Randy TaplitzDivision of Infectious Diseases, University of California San Diego, La Jolla, CA 92093.ORCID 0000-0002-0109-5991
Robert H GilmanJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.ORCID 0000-0002-9037-0712
Mayuko SaitoJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.ORCID 0000-0003-4622-7027
David M LewinsohnDepartment of Medicine, VA Portland Health Care System, Portland, OR 97239.
Alessandro SetteDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
Bjoern PetersDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0002-8457-6693
Cecilia S Lindestam ArlehamnDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0001-7302-8002
La Jolla Institute for Immunology · USJohns Hopkins University · USOregon Health & Science University · USUniversity of California San Diego · US

Funding

Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogensU19AI118626 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Pandurangan Vijayanand · 2015 to 2026
$36.7M
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCRR NIH HHS S10 RR027366NIAID NIH HHS U19 AI118626NIH HHS S10 OD016262
6 · The paper itself

Abstract

CD8 T cells are considered important contributors to the immune response against

Indexed as

Case-Control StudiesCD8-Positive T-LymphocytesFlow CytometryHistocompatibility Antigens Class IHumansLatent TuberculosisMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsMycobacterium tuberculosisHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, human

Identifiers

PMID32499216
PMCPMC7543048
OpenAlexW3034099017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.